Cargando…

Randomized Controlled Trials in Lung, Gastrointestinal, and Breast Cancers: An Overview of Global Research Activity

Background: In this study, we compared and contrasted design characteristics, results, and publications of randomized controlled trials (RCTs) in gastrointestinal (GI), lung, and breast cancer. Methods: A PUBMED search identified phase III RCTs of anticancer therapy in GI, lung, and breast cancer pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wells, J. Connor, Fundytus, Adam, Sharma, Shubham, Hopman, Wilma M., Del Paggio, Joseph C., Gyawali, Bishal, Mukherji, Deborah, Hammad, Nazik, Pramesh, C. S., Aggarwal, Ajay, Sullivan, Richard, Booth, Christopher M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9026406/ https://www.ncbi.nlm.nih.gov/pubmed/35448181 http://dx.doi.org/10.3390/curroncol29040207

Ejemplares similares

Randomised controlled trials evaluating anticancer therapies in haematological cancers: an overview of global research activity
por: Sengar, Manju, et al.
Publicado: (2023)

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
por: Sharma, Shubham, et al.
Publicado: (2021)

Participation of Lower and Upper Middle–Income Countries in Clinical Trials Led by High-Income Countries
por: Rubagumya, Fidel, et al.
Publicado: (2022)

Delivery of Global Cancer Care: An International Study of Medical Oncology Workload
por: Fundytus, Adam, et al.
Publicado: (2017)

Cancer care workforce in Africa: perspectives from a global survey
por: Vanderpuye, Verna, et al.
Publicado: (2019)

Cancer Medicines: What Is Essential and Affordable in India?
por: Sengar, Manju, et al.
Publicado: (2022)

Access to cancer medicines deemed essential by oncologists in 82 countries: an international, cross-sectional survey
por: Fundytus, Adam, et al.
Publicado: (2021)

Global cancer research in the post-pandemic world
por: Mukherji, Deborah, et al.
Publicado: (2021)

Gender differences in outcomes of cancer patients with COVID: Signal or noise?
por: Wijeratne, Don Thiwanka, et al.
Publicado: (2020)

Training of oncologists: results of a global survey
por: Jalan, Divyanshi, et al.
Publicado: (2020)

Cancer and COVID-19 vaccines: a complex global picture
por: Yusuf, Aasim, et al.
Publicado: (2021)

Overview of Delivery of Cancer Care in Nepal: Current Status and Future Priorities
por: Gyawali, Bishal, et al.
Publicado: (2020)

Defining Essential Childhood Cancer Medicines to Inform Prioritization and Access: Results From an International, Cross-Sectional Survey
por: Denburg, Avram E., et al.
Publicado: (2022)

Targeting the value of targeted therapy
por: Paggio, Joseph C. Del, et al.
Publicado: (2017)

What Global Oncology Needs: Mutual Learning and More Funding
por: Gyawali, Bishal, et al.
Publicado: (2018)

Could We Have Improved on ADAURA? Refining Global Research Practices to Reduce Cancer Care Disparities
por: West, Howard (Jack), et al.
Publicado: (2023)

Challenges of globalization of cancer drug trials- recruitment in LMICs, approval in HICs
por: Gyawali, Bishal, et al.
Publicado: (2021)

Global cancer research in the era of COVID-19: a bibliometric analysis
por: Van Hemelrijck, Mieke, et al.
Publicado: (2021)

Highlights from Choosing Wisely 2022 for Resource Limited Settings: Reducing Low Value Cancer Care for Sustainability conference, 17th-18th September, Mumbai, India
por: Akhade, Amol, et al.
Publicado: (2022)

Cancer drugs in LMICs: cheap but unaffordable
por: Gyawali, Bishal
Publicado: (2017)

The OlympiAD trial: who won the gold?
por: Gyawali, Bishal
Publicado: (2017)

Low-value practices in oncology contributing to financial toxicity
por: Gyawali, Bishal
Publicado: (2017)

Me, Too
por: Gyawali, Bishal
Publicado: (2016)

Letter to Editor-response: placebo response rates
por: Gyawali, Bishal
Publicado: (2023)

Objective response rate of placebo in randomized controlled trials of anticancer medicines
por: Sachdev, Arushi, et al.
Publicado: (2022)

Negative trials in ovarian cancer: is there such a thing as too much optimism?
por: Gyawali, Bishal, et al.
Publicado: (2016)

Adoptive cell therapy and modulation of the tumour microenvironment: new insights from ASCO 2016
por: Khoja, Leila, et al.
Publicado: (2016)

Cancer treatment in the last 6 months of life: when inaction can outperform action
por: Gyawali, Bishal, et al.
Publicado: (2018)

Bevacizumab in Advanced Cervical Cancer: Issues and Challenges for Low- and Middle-Income Countries
por: Gyawali, Bishal, et al.
Publicado: (2016)

Same Data; Different Interpretations
por: Gyawali, Bishal, et al.
Publicado: (2016)

Endpoints used in phase III randomized controlled trials of treatment options for COVID-19
por: Desai, Aakash, et al.
Publicado: (2020)

Assessing the benefits and harms of direct oral anticoagulants in patients with cancer for the prophylaxis and treatment of venous thromboembolism: a systematic review and meta-analysis
por: Desai, Aakash, et al.
Publicado: (2020)

Fall in US cancer death rates: Time to pop the champagne?
por: Desai, Aakash, et al.
Publicado: (2020)

Financial toxicity of cancer treatment: Moving the discussion from acknowledgement of the problem to identifying solutions
por: Desai, Aakash, et al.
Publicado: (2020)

Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research Groups
por: Del Paggio, Joseph C, et al.
Publicado: (2018)

Intention to probe into the colonoscopy trial: Is it the procedure or the trial that failed?
por: Knopf, Kevin B., et al.
Publicado: (2022)

Sepsis: The evolution in definition, pathophysiology, and management
por: Gyawali, Bishal, et al.
Publicado: (2019)

Assessing the risk-benefit profile of ramucirumab in patients with advanced solid tumors: A meta-analysis of randomized controlled trials
por: Effing, Sophie Marie Anne, et al.
Publicado: (2020)

A Large Pericardial Effusion Culminating in Left Lung Collapse
por: Amin, Hina, et al.
Publicado: (2019)

Assessment of Price and Clinical Benefit of Cancer Drugs in Canada, 2011-2020
por: Jenei, Kristina, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_7e0c4eoj64ub3htpbeim7km4bg